
    
      Fourteen lifetime nonsmokers with a physician diagnosis of asthma will be recruited for the
      study. All subjects will be allowed to use short-acting beta-adrenergic agonists as rescue
      medication.

      Inclusion criteria:

        1. Males and females, 18 to 65 years of age.

        2. FEV1 60-85% of predicted on the screening day.

      Exclusion criteria:

        1. Women of childbearing potential who do not use accepted birth control measures; pregnant
           and breast feeding women.

        2. Cardiovascular disease and/or use of cardiovascular medications

      2. Subjects with known beta-adrenergic agonist or glucocorticosteroid intolerance 4. Acute
      respiratory infection within four weeks prior to the study 5. Use, within two weeks prior to
      the study, of any anti-asthma medication not mentioned above
    
  